Lyra Therapeutics Inc. (LYRA)
NASDAQ: LYRA
· Real-Time Price · USD
7.06
-0.04 (-0.56%)
At close: Aug 15, 2025, 3:59 PM
6.91
-2.12%
After-hours: Aug 15, 2025, 04:40 PM EDT
Lyra Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 183K | 183K | 209K | 195K | 598K | 532K | 146K | 544K | 458K | 410K | 11K | 359K | 407K | 5.37M | 271K | 14K | n/a | n/a |
Cost of Revenue | 200K | n/a | n/a | 39K | 145K | 136K | 85K | 12.37M | 10.8M | n/a | 222K | n/a | 300K | 280K | 14K | 6.38M | 300K | 70K |
Gross Profit | -17K | 183K | 209K | 195K | -12.67M | 396K | 61K | -11.82M | -10.34M | 410K | -211K | 359K | 107K | 5.09M | 257K | -6.36M | -300K | -70K |
Operating Income | -8.43M | -8.84M | -11.41M | -12.44M | -48.97M | -23.52M | -16.48M | -16.83M | -16.5M | -17.31M | -15.15M | -14.83M | -14.52M | -7.03M | -13.64M | -11.08M | -11.06M | -7.83M |
Interest Income | 410K | 298K | 435K | 576K | 855K | 1.09M | 1.34M | 1.19M | 897K | 1.07M | 933K | 60K | 34K | 14K | 21K | 26K | 26K | 29K |
Pretax Income | -7.43M | -8.54M | -10.97M | -11.87M | -48.12M | -22.44M | -15.14M | -15.63M | -15.61M | -16.24M | -14.22M | -14.77M | -14.48M | -7.01M | -13.62M | -11.05M | -11.04M | -7.8M |
Net Income | -7.44M | -8.55M | -10.98M | -11.87M | -48.13M | -22.45M | -15.16M | -15.65M | -15.62M | -16.25M | -14.23M | -14.77M | -14.42M | -7M | -13.34M | -11.05M | -11.04M | -7.8M |
Selling & General & Admin | 3.3M | 3.26M | 3.61M | 3.93M | 5.14M | 5.82M | 4.36M | 5M | 4.57M | 5.13M | 4.4M | 5.14M | 4.13M | 3.89M | 3.57M | 4.02M | 3.56M | 3.06M |
Research & Development | 5.11M | 4.88M | 6.36M | 5.9M | 13.26M | 18.1M | 12.18M | 12.37M | 10.8M | 12.6M | 9.45M | 10.05M | 10.79M | 8.51M | 10.34M | 7.08M | 7.5M | 4.77M |
Other Expenses | n/a | 885K | 1.64M | 2.8M | 17.91M | n/a | n/a | n/a | 1.59M | n/a | 1.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 8.41M | 9.02M | 11.62M | 12.64M | 36.31M | 23.92M | 16.54M | 17.37M | 15.37M | 17.72M | 13.85M | 15.19M | 14.93M | 12.39M | 13.91M | 11.1M | 11.06M | 7.83M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.61M | 9.02M | 11.62M | 12.64M | 49.57M | 24.06M | 16.62M | 17.37M | 15.37M | 17.72M | 13.85M | 15.19M | 14.93M | 12.39M | 13.91M | 11.1M | 11.06M | 7.83M |
Income Tax Expense | 2K | 4K | 6K | 7K | 12K | 14K | 17K | -16K | 12K | 14K | 13K | n/a | -68K | -14K | -278K | -26K | -26K | -29K |
Shares Outstanding (Basic) | 1.35M | 65.76M | 65.11M | 65.46M | 65.46M | 64.01M | 61.24M | 56.95M | 43.68M | 36.83M | 31.71M | 36.83M | 33.95M | 13.01M | 12.97M | 13M | 12.99M | 12.95M |
Shares Outstanding (Diluted) | 1.35M | 65.76M | 65.11M | 65.46M | 65.46M | 64.01M | 61.53M | 56.95M | 43.68M | 36.83M | 31.83M | 36.83M | 33.95M | 13.01M | 13M | 13M | 12.99M | 12.95M |
EPS (Basic) | -5.51 | -0.13 | -0.17 | -0.18 | -0.73 | -0.35 | -0.25 | -0.27 | -0.36 | -0.44 | -0.45 | -0.4 | -0.42 | -0.92 | -1.05 | -0.85 | -0.85 | -0.6 |
EPS (Diluted) | -5.51 | -0.13 | -0.17 | -0.18 | -0.73 | -0.35 | -0.25 | -0.27 | -0.36 | -0.44 | -0.45 | -0.4 | -0.42 | -0.92 | -1.05 | -0.85 | -0.85 | -0.6 |
EBITDA | -7.24M | -8.41M | -9.62M | -9.6M | -17.66M | -23.39M | -16.39M | -16.83M | -14.91M | -17.03M | -13.62M | -14.55M | -14.11M | -11.64M | -13.36M | -10.73M | -10.76M | -7.76M |
EBIT | -7.43M | -8.54M | -9.77M | -9.64M | -17.8M | -23.52M | -16.48M | -16.83M | -14.91M | -17.31M | -13.84M | -14.83M | -14.4M | -11.93M | -13.64M | -11.08M | -11.06M | -7.83M |
Depreciation & Amortization | 200K | 128K | 151K | 39K | 145K | 136K | 85K | -68K | -23K | 284K | 222K | 279K | 300K | 280K | 278K | 400K | 300K | 70K |